To analyze the epidemiology of patent ductus arteriosus (PDA) and outcomes of transcatheter closure in neonates in Qatar.
Approach:
Study Design: Retrospective analysis of 80 infants diagnosed with PDA at Sidra Medicine, Qatar, from 2018 to 2024.
Data Collection: Data obtained from electronic health records, including demographics, PDA characteristics, and treatment outcomes.
Statistical Analysis: Statistical analysis performed using SPSS version 29, with significance set at p ≤ 0.05.
Key Findings:
60% of patients were male and 83.75% were born prematurely.
Transcatheter device closure was performed in 65% of patients.
Gestational age <37 weeks significantly associated with catheter-based treatment (p ≤ 0.05).
PDA murmur increased likelihood of catheter-based intervention eightfold (OR 8.125; p < 0.001).
Implant success rate was 86.5% on the first attempt and 100% after repeat intervention.
Intraprocedural complications included device embolization in 4 patients.
Residual shunt resolved in all patients with follow-up data at six months.
Interpretation:
PDA closure via transcatheter approach shows high success rates and acceptable safety in preterm infants, with gestational age, birth weight, and ductal size being key factors influencing outcomes.
Limitations:
Study excluded patients requiring surgical intervention, which may limit generalizability based on the study design.
Retrospective design may introduce selection bias related to patient selection.
Conclusion:
Transcatheter closure of PDA is feasible in preterm infants, emphasizing the importance of patient selection.
In a nationwide Finnish cohort, patients with atrial fibrillation and gout had higher ischemic stroke rates, while urate-lowering therapy was associated with lower stroke rates.